Report for Imig JD

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (28)

Title : Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis - Khan_2023_Front.Immunol_14_1269261
Author(s) : Khan MAH , Nolan B , Stavniichuk A , Merk D , Imig JD
Ref : Front Immunol , 14 :1269261 , 2023
Abstract : Khan_2023_Front.Immunol_14_1269261
ESTHER : Khan_2023_Front.Immunol_14_1269261
PubMedSearch : Khan_2023_Front.Immunol_14_1269261
PubMedID: 38235144

Title : Dual sEH\/COX-2 Inhibition Using PTUPB-A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity - Jankiewicz_2021_Front.Pharmacol_12_744776
Author(s) : Jankiewicz WK , Barnett SD , Stavniichuk A , Hwang SH , Hammock BD , Belayet JB , Khan AH , Imig JD
Ref : Front Pharmacol , 12 :744776 , 2021
Abstract : Jankiewicz_2021_Front.Pharmacol_12_744776
ESTHER : Jankiewicz_2021_Front.Pharmacol_12_744776
PubMedSearch : Jankiewicz_2021_Front.Pharmacol_12_744776
PubMedID: 34955823

Title : Epoxylipids and soluble epoxide hydrolase in heart diseases - Imig_2021_Biochem.Pharmacol_195_114866
Author(s) : Imig JD , Cervenka L , Neckar J
Ref : Biochemical Pharmacology , 195 :114866 , 2021
Abstract : Imig_2021_Biochem.Pharmacol_195_114866
ESTHER : Imig_2021_Biochem.Pharmacol_195_114866
PubMedSearch : Imig_2021_Biochem.Pharmacol_195_114866
PubMedID: 34863976

Title : Multitarget molecule,PTUPB, to treat diabetic nephropathy in rats - Hye_2021_Br.J.Pharmacol_178_4468
Author(s) : Hye Khan MA , Hwang SH , Barnett SD , Stavniichuk A , Jankiewicz WK , Hammock BD , Imig JD
Ref : British Journal of Pharmacology , 178 :4468 , 2021
Abstract : Hye_2021_Br.J.Pharmacol_178_4468
ESTHER : Hye_2021_Br.J.Pharmacol_178_4468
PubMedSearch : Hye_2021_Br.J.Pharmacol_178_4468
PubMedID: 34255857

Title : Multi-Target Approaches in Metabolic Syndrome - Lillich_2020_Front.Pharmacol_11_554961
Author(s) : Lillich FF , Imig JD , Proschak E
Ref : Front Pharmacol , 11 :554961 , 2020
Abstract : Lillich_2020_Front.Pharmacol_11_554961
ESTHER : Lillich_2020_Front.Pharmacol_11_554961
PubMedSearch : Lillich_2020_Front.Pharmacol_11_554961
PubMedID: 33776749

Title : Dual Soluble Epoxide Hydrolase Inhibitor\/PPAR-gamma Agonist Attenuates Renal Fibrosis - Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
Author(s) : Stavniichuk A , Hye Khan MA , Yeboah MM , Chesnik MA , Jankiewicz WK , Hartmann M , Blocher R , Kircher T , Savchuk O , Proschak E , Imig JD
Ref : Prostaglandins Other Lipid Mediat , :106472 , 2020
Abstract : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
ESTHER : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
PubMedSearch : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
PubMedID: 32569747

Title : Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture - Imig_2020_Hypertension__HYPERTENSIONAHA12013898
Author(s) : Imig JD , Jankiewicz WK , Khan AH
Ref : Hypertension , :HYPERTENSIONAHA12013898 , 2020
Abstract : Imig_2020_Hypertension__HYPERTENSIONAHA12013898
ESTHER : Imig_2020_Hypertension__HYPERTENSIONAHA12013898
PubMedSearch : Imig_2020_Hypertension__HYPERTENSIONAHA12013898
PubMedID: 32475311

Title : Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors -
Author(s) : Imig JD , Morisseau C
Ref : Front Pharmacol , 11 :598858 , 2020
PubMedID: 33071800

Title : Epigenetic soluble epoxide hydrolase regulation causes endothelial dysfunction -
Author(s) : Imig JD
Ref : Acta Physiol (Oxf) , 225 :e13203 , 2019
PubMedID: 30307705

Title : A dual farnesoid X receptor\/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice - Hye_2019_Biochem.Pharmacol_166_212
Author(s) : Hye Khan MA , Schmidt J , Stavniichuk A , Imig JD , Merk D
Ref : Biochemical Pharmacology , 166 :212 , 2019
Abstract : Hye_2019_Biochem.Pharmacol_166_212
ESTHER : Hye_2019_Biochem.Pharmacol_166_212
PubMedSearch : Hye_2019_Biochem.Pharmacol_166_212
PubMedID: 31129048

Title : Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats - Vackova_2019_Front.Pharmacol_10_18
Author(s) : Vackova S , Kopkan L , Kikerlova S , Huskova Z , Sadowski J , Kompanowska-Jezierska E , Hammock BD , Imig JD , Taborsky M , Melenovsky V , Cervenka L
Ref : Front Pharmacol , 10 :18 , 2019
Abstract : Vackova_2019_Front.Pharmacol_10_18
ESTHER : Vackova_2019_Front.Pharmacol_10_18
PubMedSearch : Vackova_2019_Front.Pharmacol_10_18
PubMedID: 30728778

Title : Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula - Kala_2018_Physiol.Res_67_401
Author(s) : Kala P , Sedlakova L , Skaroupkova P , Kopkan L , Vanourkova Z , Taborsky M , Nishiyama A , Hwang SH , Hammock BD , Sadowski J , Melenovsky V , Imig JD , Cervenka L
Ref : Physiol Res , 67 :401 , 2018
Abstract : Kala_2018_Physiol.Res_67_401
ESTHER : Kala_2018_Physiol.Res_67_401
PubMedSearch : Kala_2018_Physiol.Res_67_401
PubMedID: 29527914

Title : Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5\/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease - Certikova_2018_Kidney.Blood.Press.Res_43_329
Author(s) : Certikova Chabova V , Kujal P , Skaroupkova P , Varnourkova Z , Vackova S , Huskova Z , Kikerlova S , Sadowski J , Kompanowska-Jezierska E , Baranowska I , Hwang SH , Hammock BD , Imig JD , Tesar V , Cervenka L
Ref : Kidney Blood Press Res , 43 :329 , 2018
Abstract : Certikova_2018_Kidney.Blood.Press.Res_43_329
ESTHER : Certikova_2018_Kidney.Blood.Press.Res_43_329
PubMedSearch : Certikova_2018_Kidney.Blood.Press.Res_43_329
PubMedID: 29529602

Title : Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia - Bettaieb_2017_Biochim.Biophys.Acta_1861_2758
Author(s) : Bettaieb A , Koike S , Hsu MF , Ito Y , Chahed S , Bachaalany S , Gruzdev A , Calvo-Rubio M , Lee KSS , Inceoglu B , Imig JD , Villalba JM , Zeldin DC , Hammock BD , Haj FG
Ref : Biochimica & Biophysica Acta , 1861 :2758 , 2017
Abstract : Bettaieb_2017_Biochim.Biophys.Acta_1861_2758
ESTHER : Bettaieb_2017_Biochim.Biophys.Acta_1861_2758
PubMedSearch : Bettaieb_2017_Biochim.Biophys.Acta_1861_2758
PubMedID: 28757338

Title : Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula - Cervenka_2015_Physiol.Res_64_857
Author(s) : Cervenka L , Melenovsky V , Huskova Z , Sporkova A , Burgelova M , Skaroupkova P , Hwang SH , Hammock BD , Imig JD , Sadowski J
Ref : Physiol Res , 64 :857 , 2015
Abstract : Cervenka_2015_Physiol.Res_64_857
ESTHER : Cervenka_2015_Physiol.Res_64_857
PubMedSearch : Cervenka_2015_Physiol.Res_64_857
PubMedID: 26047375

Title : 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications - Falck_2014_J.Med.Chem_57_6965
Author(s) : Falck JR , Koduru SR , Mohapatra S , Manne R , Atcha KR , Atcha R , Manthati VL , Capdevila JH , Christian S , Imig JD , Campbell WB
Ref : Journal of Medicinal Chemistry , 57 :6965 , 2014
Abstract : Falck_2014_J.Med.Chem_57_6965
ESTHER : Falck_2014_J.Med.Chem_57_6965
PubMedSearch : Falck_2014_J.Med.Chem_57_6965
PubMedID: 25119815

Title : Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy - Kim_2014_Am.J.Physiol.Renal.Physiol__ajprenal 00531 2014
Author(s) : Kim J , Yoon SP , Toews ML , Imig JD , Hwang SH , Hammock BD , Padanilam BJ
Ref : American Journal of Physiology Renal Physiol , :ajprenal 00531 2014 , 2014
Abstract : Kim_2014_Am.J.Physiol.Renal.Physiol__ajprenal 00531 2014
ESTHER : Kim_2014_Am.J.Physiol.Renal.Physiol__ajprenal 00531 2014
PubMedSearch : Kim_2014_Am.J.Physiol.Renal.Physiol__ajprenal 00531 2014
PubMedID: 25377915

Title : Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system - Varcabova_2013_Clin.Exp.Pharmacol.Physiol_40_273
Author(s) : Varcabova S , Huskova Z , Kramer HJ , Hwang SH , Hammock BD , Imig JD , Kitada K , Cervenka L
Ref : Clinical & Experimental Pharmacology & Physiology , 40 :273 , 2013
Abstract : Varcabova_2013_Clin.Exp.Pharmacol.Physiol_40_273
ESTHER : Varcabova_2013_Clin.Exp.Pharmacol.Physiol_40_273
PubMedSearch : Varcabova_2013_Clin.Exp.Pharmacol.Physiol_40_273
PubMedID: 23039246

Title : Soluble Epoxide Hydrolase Inhibition Exhibits Antihypertensive Actions Independently of Nitric Oxide in Mice with Renovascular Hypertension - Kopkan_2012_Kidney.Blood.Press.Res_35_595
Author(s) : Kopkan L , Huskova Z , Sporkova A , Varcabova S , Honetschlagerova Z , Hwang SH , Tsai HJ , Hammock BD , Imig JD , Kramer HJ , Burgelova M , Vojtiskova A , Kujal P , Vernerova Z , Cervenka L
Ref : Kidney Blood Press Res , 35 :595 , 2012
Abstract : Kopkan_2012_Kidney.Blood.Press.Res_35_595
ESTHER : Kopkan_2012_Kidney.Blood.Press.Res_35_595
PubMedSearch : Kopkan_2012_Kidney.Blood.Press.Res_35_595
PubMedID: 22948718

Title : Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension - Neckar_2012_Clin.Sci.(Lond)_122_513
Author(s) : Neckar J , Kopkan L , Huskova Z , Kolar F , Papousek F , Kramer HJ , Hwang SH , Hammock BD , Imig JD , Maly J , Netuka I , Ostadal B , Cervenka L
Ref : Clinical Science (Lond) , 122 :513 , 2012
Abstract : Neckar_2012_Clin.Sci.(Lond)_122_513
ESTHER : Neckar_2012_Clin.Sci.(Lond)_122_513
PubMedSearch : Neckar_2012_Clin.Sci.(Lond)_122_513
PubMedID: 22324471

Title : Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles - Gauthier_2011_Am.J.Physiol.Renal.Physiol_301_F765
Author(s) : Gauthier KM , Olson L , Harder A , Isbell M , Imig JD , Gutterman DD , Falck JR , Campbell WB
Ref : American Journal of Physiology Renal Physiol , 301 :F765 , 2011
Abstract : Gauthier_2011_Am.J.Physiol.Renal.Physiol_301_F765
ESTHER : Gauthier_2011_Am.J.Physiol.Renal.Physiol_301_F765
PubMedSearch : Gauthier_2011_Am.J.Physiol.Renal.Physiol_301_F765
PubMedID: 21753077

Title : Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension - Honetschlagerova_2011_J.Physiol_589_207
Author(s) : Honetschlagerova Z , Z ZH , Vanourkova Z , Sporkova A , Kramer HJ , Hwang SH , Tsai HJ , Hammock BD , Imig JD , Cervenka L , Kopkan L
Ref : The Journal of Physiology , 589 :207 , 2011
Abstract : Honetschlagerova_2011_J.Physiol_589_207
ESTHER : Honetschlagerova_2011_J.Physiol_589_207
PubMedSearch : Honetschlagerova_2011_J.Physiol_589_207
PubMedID: 21078594

Title : Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases - Imig_2009_Nat.Rev.Drug.Discov_8_794
Author(s) : Imig JD , Hammock BD
Ref : Nat Rev Drug Discov , 8 :794 , 2009
Abstract : Imig_2009_Nat.Rev.Drug.Discov_8_794
ESTHER : Imig_2009_Nat.Rev.Drug.Discov_8_794
PubMedSearch : Imig_2009_Nat.Rev.Drug.Discov_8_794
PubMedID: 19794443

Title : Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension - Manhiani_2009_Am.J.Physiol.Renal.Physiol_297_F740
Author(s) : Manhiani M , Quigley JE , Knight SF , Tasoobshirazi S , Moore T , Brands MW , Hammock BD , Imig JD
Ref : American Journal of Physiology Renal Physiol , 297 :F740 , 2009
Abstract : Manhiani_2009_Am.J.Physiol.Renal.Physiol_297_F740
ESTHER : Manhiani_2009_Am.J.Physiol.Renal.Physiol_297_F740
PubMedSearch : Manhiani_2009_Am.J.Physiol.Renal.Physiol_297_F740
PubMedID: 19553349

Title : Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels - Olearczyk_2006_J.Pharmacol.Exp.Ther_318_1307
Author(s) : Olearczyk JJ , Field MB , Kim IH , Morisseau C , Hammock BD , Imig JD
Ref : Journal of Pharmacology & Experimental Therapeutics , 318 :1307 , 2006
Abstract : Olearczyk_2006_J.Pharmacol.Exp.Ther_318_1307
ESTHER : Olearczyk_2006_J.Pharmacol.Exp.Ther_318_1307
PubMedSearch : Olearczyk_2006_J.Pharmacol.Exp.Ther_318_1307
PubMedID: 16772540
Gene_locus related to this paper: human-EPHX2

Title : Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats - Zhao_2005_Am.J.Physiol.Regul.Integr.Comp.Physiol_288_R188
Author(s) : Zhao X , Dey A , Romanko OP , Stepp DW , Wang MH , Zhou Y , Jin L , Pollock JS , Webb RC , Imig JD
Ref : American Journal of Physiology Regul Integr Comp Physiol , 288 :R188 , 2005
Abstract : Zhao_2005_Am.J.Physiol.Regul.Integr.Comp.Physiol_288_R188
ESTHER : Zhao_2005_Am.J.Physiol.Regul.Integr.Comp.Physiol_288_R188
PubMedSearch : Zhao_2005_Am.J.Physiol.Regul.Integr.Comp.Physiol_288_R188
PubMedID: 15345471

Title : Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage - Zhao_2004_J.Am.Soc.Nephrol_15_1244
Author(s) : Zhao X , Yamamoto T , Newman JW , Kim IH , Watanabe T , Hammock BD , Stewart J , Pollock JS , Pollock DM , Imig JD
Ref : J Am Soc Nephrol , 15 :1244 , 2004
Abstract : Zhao_2004_J.Am.Soc.Nephrol_15_1244
ESTHER : Zhao_2004_J.Am.Soc.Nephrol_15_1244
PubMedSearch : Zhao_2004_J.Am.Soc.Nephrol_15_1244
PubMedID: 15100364

Title : Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension - Imig_2002_Hypertension_39_690
Author(s) : Imig JD , Zhao X , Capdevila JH , Morisseau C , Hammock BD
Ref : Hypertension , 39 :690 , 2002
Abstract : Imig_2002_Hypertension_39_690
ESTHER : Imig_2002_Hypertension_39_690
PubMedSearch : Imig_2002_Hypertension_39_690
PubMedID: 11882632